Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Journal of Clinical Medicine|May 11, 2019
Urinary Stem Cells as Tools to Study Genetic Disease: Overview of the LiteratureMaria Sofia Falzarano, Alessandra FerliniNucleic Acid Therapeutics|February 11, 2014
Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophyMaria Sofia Falzarano, Chiara Passarelli, Alessandra FerliniJournal of Clinical Medicine|March 6, 2021
Innovative Therapeutic Approaches for Duchenne Muscular DystrophyFernanda Fortunato, Rachele Rossi, Maria Sofia Falzarano, et al.Molecules (Basel, Switzerland)|October 13, 2015
Duchenne Muscular Dystrophy: From Diagnosis to TherapyMaria Sofia Falzarano, Chiara Scotton, Chiara Passarelli, et al.Molecules (Basel, Switzerland)|April 6, 2017
Antisense Oligonucleotide-Based Therapy for Neuromuscular DiseaseValentina Sardone, Haiyan Zhou, Francesco Muntoni, et al.Human Gene Therapy|September 23, 2014
Biodistribution studies of polymeric nanoparticles for drug delivery in miceMaria Sofia Falzarano, Elena Bassi, Chiara Passarelli, et al.Human Mutation|January 7, 2012
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome arrayMatteo Bovolenta, Chiara Scotton, Maria Sofia Falzarano, et al.Current Pharmaceutical Design|January 11, 2018
Nanodiagnostics and Nanodelivery Applications in Genetic AlterationsMaria Sofia Falzarano, Cristina Flesia, Roberta Cavalli, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|July 9, 2003
Synthetic formyl tripeptide chemoattractants: a C(alpha,alpha)-dialkylated, amphiphilic glycyl residue at position 1Renata Witkowska, Janusz Zabrocki, Susanna Spisani, et al.Bioorganic & Medicinal Chemistry Letters|May 4, 2007
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxisOlga Bruno, Chiara Brullo, Francesco Bondavalli, et al.Pageof 3